{
    "symbol": "AIN",
    "quarter": 3,
    "year": 2022,
    "date": "2022-10-25 13:14:06",
    "content": " Third quarter selling, technical, general and research expenses were $46.8 million in the current quarter, down slightly from $47.4 million in the prior year quarter and were down as a percentage of net sales from 20.4% to 18.0%, driven by the impact of foreign exchange rates on MC, FTGNR partially offset by increased investments this year in R&D and selling expense. We are also updating our previously issued guidance ranges for company level performance, including revenue up between $990 million and $1.01 billion, increase from prior guidance of $970 million to $1.01 billion, effective income tax rate of 25% to 27% down from 28% to 30%, depreciation and amortization of between $71 million and $72 million unchanged from prior year guidance, capital expenditure is in the range of $75 million to $85 million, unchanged from prior guidance, GAAP earnings per share of between $2.84 and $3.14, reduced from prior guidance of $3.45 to $3.75, aAdjusted earnings per share of between $3.50 and $3.80 increased from prior guidance of $3.30 to $3.60 and adjusted EBITDA of between $240 million and $255 million increased from prior guidance of $230 million to $250 million."
}